BNP Paribas Financial Markets Takes Position in Mineralys Therapeutics, Inc. (NASDAQ:MLYS)
BNP Paribas Financial Markets acquired a new stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,895 shares of the company’s stock, valued at approximately $48,000. Several other institutional investors and […]
BNP Paribas Financial Markets acquired a new stake in Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,895 shares of the company’s stock, valued at approximately $48,000. Several other institutional investors and […]
